Clinical Trial Update: Single-arm Trial to Evaluate the Biodistribution and Shedding of Talimogene Laherparepvec [Phase 2]

View source ↗

Summary

Phase 2 single-arm trial assessing biodistribution and shedding of talimogene laherparepvec in melanoma patients; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Talimogene laherparepvec (talimogene laherparepvec)

Snippet

Sponsor: Amgen | Conditions: Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2017-02-14